A detailed history of Man Group PLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Man Group PLC holds 108,472 shares of REGN stock, worth $106 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares
108,472
Previous 93,560 15.94%
Holding current value
$106 Million
Previous $82.2 Million 27.05%
% of portfolio
0.27%
Previous 0.24%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$902.69 - $993.35 $13.5 Million - $14.8 Million
14,912 Added 15.94%
108,472 $104 Million
Q4 2023

Feb 14, 2024

BUY
$775.18 - $881.7 $41.2 Million - $46.9 Million
53,173 Added 131.66%
93,560 $82.2 Million
Q3 2023

Nov 14, 2023

SELL
$692.45 - $844.37 $52.8 Million - $64.4 Million
-76,249 Reduced 65.37%
40,387 $33.2 Million
Q2 2023

Aug 14, 2023

BUY
$700.03 - $830.35 $60.6 Million - $71.8 Million
86,518 Added 287.26%
116,636 $83.8 Million
Q1 2023

May 15, 2023

SELL
$680.49 - $826.97 $32 Million - $38.9 Million
-47,002 Reduced 60.95%
30,118 $24.7 Million
Q4 2022

Feb 14, 2023

BUY
$705.89 - $766.39 $40.6 Million - $44 Million
57,473 Added 292.53%
77,120 $55.6 Million
Q3 2022

Nov 14, 2022

SELL
$573.97 - $724.32 $10.8 Million - $13.7 Million
-18,903 Reduced 49.04%
19,647 $13.5 Million
Q2 2022

Aug 15, 2022

BUY
$548.35 - $738.84 $4.7 Million - $6.34 Million
8,580 Added 28.63%
38,550 $22.8 Million
Q1 2022

May 16, 2022

SELL
$595.12 - $698.43 $69.8 Million - $81.9 Million
-117,219 Reduced 79.64%
29,970 $20.9 Million
Q4 2021

Feb 14, 2022

BUY
$543.48 - $670.97 $36.3 Million - $44.8 Million
66,819 Added 83.14%
147,189 $93 Million
Q3 2021

Nov 15, 2021

SELL
$574.03 - $680.96 $16.4 Million - $19.5 Million
-28,583 Reduced 26.23%
80,370 $48.6 Million
Q2 2021

Aug 16, 2021

SELL
$472.8 - $558.54 $5.35 Million - $6.32 Million
-11,314 Reduced 9.41%
108,953 $60.9 Million
Q1 2021

May 17, 2021

BUY
$446.73 - $548.2 $33.5 Million - $41.1 Million
74,920 Added 165.21%
120,267 $56.9 Million
Q4 2020

Feb 16, 2021

BUY
$478.3 - $607.98 $8.15 Million - $10.4 Million
17,041 Added 60.2%
45,347 $21.9 Million
Q3 2020

Nov 16, 2020

SELL
$544.75 - $658.21 $3.08 Million - $3.72 Million
-5,658 Reduced 16.66%
28,306 $15.8 Million
Q2 2020

Aug 14, 2020

BUY
$493.32 - $643.92 $1.62 Million - $2.11 Million
3,280 Added 10.69%
33,964 $21.2 Million
Q1 2020

May 15, 2020

BUY
$336.18 - $494.43 $794,393 - $1.17 Million
2,363 Added 8.34%
30,684 $15 Million
Q4 2019

Feb 18, 2020

BUY
$274.13 - $376.51 $3.75 Million - $5.16 Million
13,695 Added 93.63%
28,321 $10.6 Million
Q3 2019

Nov 14, 2019

SELL
$273.46 - $318.39 $651,655 - $758,723
-2,383 Reduced 14.01%
14,626 $4.06 Million
Q2 2019

Aug 14, 2019

BUY
$299.6 - $414.82 $3.89 Million - $5.38 Million
12,980 Added 322.16%
17,009 $5.33 Million
Q1 2019

May 15, 2019

SELL
$372.08 - $439.57 $612,815 - $723,971
-1,647 Reduced 29.02%
4,029 $1.65 Million
Q4 2018

Feb 14, 2019

SELL
$335.82 - $403.04 $164,551 - $197,489
-490 Reduced 7.95%
5,676 $2.12 Million
Q3 2018

Nov 14, 2018

SELL
$351.14 - $408.51 $25,984 - $30,229
-74 Reduced 1.19%
6,166 $2.49 Million
Q2 2018

Aug 14, 2018

SELL
$284.6 - $344.99 $11,668 - $14,144
-41 Reduced 0.65%
6,240 $2.15 Million
Q1 2018

May 15, 2018

BUY
$315.82 - $393.78 $1.98 Million - $2.47 Million
6,281 New
6,281 $2.16 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $105B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Man Group PLC Portfolio

Follow Man Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.